Identification of Genomic Markers and Immune Repertoires for Combinations of Immunotherapy with Metronomic Chemotherapy or Radiofrequency Thermal Ablation in Pancreatic Ductal Adenocarcinoma( I )

Project: A - Government Institutionb - Ministry of Science and Technology

Project Details

Effective start/end date8/1/197/31/20


  • Pancreatic ductal adenocarcinoma
  • tumor microenvironment
  • T-Cell Receptor repertoire
  • Immune therapy
  • Pharmacogenomics